Translational Cancer Mechanisms and Therapy BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody
ID：am030003M0035140dkmn27080📫 -页
内容摘要
Translational Cancer Mechanisms and Therapy BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody
海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方，仅供网友学习交流，请勿商用!
